Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electric fields for warming cryopreserved tissue.

Cryobiology·2026
Same author

In Memoriam - William F. Rall: Impacting science, impacting people.

Cryobiology·2025
Same author

55 MHz constant field dielectric warming of kidneys and ovaries cryopreserved by vitrification.

Cryobiology·2025
Same author

Biostasis: A Roadmap for Research in Preservation and Potential Revival of Humans.

Brain sciences·2024
Same author

27 MHz constant field dielectric warming of kidneys cryopreserved by vitrification.

Cryobiology·2024
Same author

Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity.

Cryobiology·2024

Related Experiment Video

Updated: Jul 17, 2026

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
09:35

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts

Published on: March 2, 2017

Improved vitrification solutions based on the predictability of vitrification solution toxicity.

Gregory M Fahy1, Brian Wowk, Jun Wu

  • 121st Century Medicine, Inc., 10844 Edison Court, Rancho Cucamonga, CA 91730, USA. gfahy@21cm.com

Cryobiology
|February 19, 2004
PubMed
Summary

New cryoprotectant solutions minimize toxicity and ice formation, enabling successful long-term preservation of tissues and organs. This breakthrough offers hope for organ transplantation and regenerative medicine advancements.

More Related Videos

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Vitrification of Ovarian Cortex Tissue to Achieve a Glassy State of Aggregation
05:53

Vitrification of Ovarian Cortex Tissue to Achieve a Glassy State of Aggregation

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Jul 17, 2026

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
09:35

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts

Published on: March 2, 2017

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Vitrification of Ovarian Cortex Tissue to Achieve a Glassy State of Aggregation
05:53

Vitrification of Ovarian Cortex Tissue to Achieve a Glassy State of Aggregation

Published on: August 9, 2024

Area of Science:

  • Cryobiology
  • Biotechnology
  • Regenerative Medicine

Background:

  • Long-term preservation of tissues and organs is hindered by cryoprotectant toxicity and ice formation.
  • Existing vitrification solutions face challenges in balancing non-toxicity with ice-free preservation.

Purpose of the Study:

  • To develop novel cryoprotectant solutions with reduced toxicity for improved organ and tissue preservation.
  • To investigate the relationship between cryoprotectant properties and toxicity.

Main Methods:

  • A new theory on cryoprotectant toxicity was applied to design and test novel vitrification solutions.
  • Evaluated toxicity using rabbit renal cortical slices and assessed viability of mouse ova and rabbit kidneys post-vitrification.

Main Results:

  • New solutions demonstrated significantly lower toxicity compared to existing ones.
  • Vitrified mouse ova showed 80% developmental rate to blastocysts, compared to 30% with previous best solutions.
  • Rabbit kidneys vitrified with new solutions showed no damage after transplantation.

Conclusions:

  • Cryoprotectant toxicity is proportional to water hydrogen bonding strength; solutions minimizing intracellular water perturbation are superior.
  • Novel cryoprotectant solutions offer new possibilities for successful vitrification of natural and engineered organs.